Instil Bio, Inc. (TIL) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$8.02
-1.35%
Mkt Cap $60.36M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 27, 2026 | $1.90M | — | — | -$2.31 | -$1.21 | +47.62% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$2.00 | -$2.01 | -0.50% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$1.72 | -$3.24 | -88.37% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$2.02 | -$4.32 | -113.86% | — | — |
| Q1 2025 Mar 4, 2025 | — | — | — | -$3.75 | -$1.82 | +51.47% | — | — |
| Q4 2024 Nov 13, 2024 | $1.90M | — | — | -$2.08 | -$3.54 | -70.19% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$3.04 | -$2.29 | +24.67% | — | — |
| Q2 2024 May 10, 2024 | — | — | — | -$2.16 | -$3.74 | -73.15% | — | — |
| Q1 2024 Mar 21, 2024 | — | $7.67M | — | -$2.84 | -$1.99 | +29.93% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$2.80 | -$10.40 | -271.43% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$4.00 | -$2.20 | +45.00% | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | -$9.00 | -$7.20 | +20.00% | — | — |
| Q1 2023 Mar 27, 2023 | $500.00K | — | — | -$0.41 | -$8.29 | -1922.39% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$8.80 | -$7.40 | +15.91% | — | — |
| Q3 2022 Aug 12, 2022 | — | — | — | -$8.00 | -$8.00 | +0.00% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$7.60 | -$7.20 | +5.26% | — | — |
| Q1 2022 Mar 7, 2022 | — | — | — | -$7.40 | -$8.60 | -16.22% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$6.60 | -$6.60 | +0.00% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$4.20 | -$5.40 | -28.57% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$0.52 | -$0.66 | -26.92% | — | — |
| Q1 2021 Mar 22, 2021 | — | $52.00K | — | — | -$0.12 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$0.49 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | $42.00K | — | — | -$0.15 | — | — | — |
| Q1 2020 Mar 31, 2020 | — | $44.00K | — | — | -$0.07 | — | — | — |